Hypertension in ethnic groups: Epidemiological and clinical perspectives

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 8, 2009, Pages 955-963

  Dwivedi, Girish ^a   Beevers, D Gareth ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

African origin; Antihypertensive drug; Asian origin; European origin; Hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE; LOSARTAN; PLACEBO; RAMIPRIL; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT; RENIN;

ABDOMINAL OBESITY; ADRENERGIC SYSTEM; AFRICAN AMERICAN; ANGIONEUROTIC EDEMA; CHINA; CLINICAL TRIAL; DRUG RESPONSE; ENVIRONMENTAL FACTOR; ETHNICITY; HEALTH CARE DELIVERY; HEART LEFT VENTRICLE FAILURE; HISPANIC; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; JAPAN; LIFESTYLE; PLASMA RENIN ACTIVITY; PREVALENCE; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT LOADING; SOCIAL STATUS; SODIUM RESTRICTION; SOUTH ASIA; URBAN AREA; DRUG EFFECT; ETHNIC GROUP; ETHNOLOGY; METABOLISM; RACE; SOCIOECONOMICS;

ANTIHYPERTENSIVE AGENTS; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; HUMANS; HYPERTENSION; LIFE STYLE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SOCIOECONOMIC FACTORS;

EID: 70350451972     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.88     Document Type: Review

References (60)

1. Donnison CP. Blood pressure in the African native: its bearing upon aetiology of hyperpiesia and athero-sclerosis. Lancet 1, 6-7 (1929).
2. Shaper AG, Leonard PJ, Jones KW, Jones M. Environmental effects on the body build, blood pressure and blood chemistry of nomadic warriors serving in the army in Kenya. East Afr. Med. J. 46, 282-289 (1969).
3. Sever PS, Gordon G, Peart WS, Beighton P. Blood pressure and its correlates in urban and tribal Africa. Lancet 2, 60-64 (1980). (Pubitemid 10064918)
4. Wilson TW, Hollifield LR, Grim CE. Systolic blood pressure levels in Black populations in sub-Sahara Africa, the West Indies and the United States: a metaanalysis. Hypertension 18 (3), 187-191 (1991).
5. Cruickshank JK, Mbanya JC, Wilks R, Balkau B, McFarlane-Anderson N, Forrester T. Sick genes, sick individuals or sick populations with chronic disease? The emergence of diabetes and high blood pressure in African-origin populations. Int. J. Epidemiol. 30, 111-117 (2001). (Pubitemid 32203798)
6. Poulter NR, Khaw KT, Hopwood BE et al. The Kenyan Lou migration study: observations on the initiation of a rise in blood pressure. Br. Med. J. 300, 967-972 (1990). • Revealed implications of the epidemiological transition in Africa.
7. Stamler J, Stamler R, Reidlinger QF, Alger G, Roberts RH. Hypertension screening in 1 million Americans: Community Hypertension Evaluation Clinic (CHEC) Program, 1973 through 1975. JAMA 235, 2299-2306 (1976).
8. Hypertension Detection and Follow-up Program Cooperative Group. Blood pressure studies in 14 communities: a two-stage screen for hypertension. JAMA 237, 2385-2391 (1977).
9. The INTERSALT study. An international co-operative study of electrolyte excretion and blood pressure: further results. J. Hum. Hypertens. 3, 279-407 (1989).
10. Charlton KE, Steyn K, Levitt NS et al. Diet and blood pressure in South Africa: intake of foods containing sodium, potassium, calcium, and magnesium in three ethnic groups. Nutrition 2, 39-50 (2005). (Pubitemid 40127564)
11. Cruickshank JK, Mbanya JC, Wilks R et al. Hypertension in four African-origin populations: current 'rules of halves' quality of blood pressure control and attributable risk of cardiovascular disease. J. Hypertens. 19, 41-46 (2001).
12. Haines AP, Booroff A, Goldenberg E, Morgan P, Singh M, Wallace P. Blood pressure, smoking, obesity and alcohol consumption in Black and White patients in general practice. J. Hum. Hypertens. 1, 39-46 (1987). (Pubitemid 18057011)
13. Lane D, Beevers DG, Lip GYH. Ethnic differences in blood pressure and the prevalence of hypertension in England. J. Hum. Hypertens. 16, 267-273 (2002). (Pubitemid 34441163)
14. Agyemang C, Bhopal R. Is the blood pressure of people from African origin adults in the UK higher or lower than that in European origin White people? A review of cross-sectional data. J. Hum. Hypertens. 17, 523-534 (2003). • Population study from the UK that showed very minor differences in average blood pressure and in the prevalence of hypertension in African-origin adults compared with European-origin White adults. (Pubitemid 36949447)
15. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stanler J. Mortality differences between Black and White men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet 351, 934-939 (1998). (Pubitemid 28138466)
16. Wilson TW, Grim CE. Biohistory of slavery and blood pressure differences in Blacks today. A hypothesis. Hypertension 17(1), 122-128 (1992).
17. Adams-Campbell LL, Nwankwo MU, Ukoli FA, Janney C. Sex and ethnic differences associated with urinary sodium and potassium in African-American US White and Nigerian college students. J. Hum. Hypertens. 7, 437-441 (1993). (Pubitemid 23310604)
18. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49, 69-75 (2007).
19. Harland JO, Unwin N, Bhopal RS et al. Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. J. Epidemiol. Community Health 51, 636-642 (1997). (Pubitemid 28014239)
20. Agyemang C, Bhopal RS. Is blood pressure of South Asian adults in the UK higher or lower than that in European White adults? A review of cross sectional data. J. Hum. Hypertens. 16, 739-751 (2002). (Pubitemid 36007927)
21. Miller GJ, Kotecha S, Wilkinson WH et al. Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis 70, 63-72 (1998).
22. Bhatnagar D, Anand IS, Durrington PN et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 345, 405-409 (1995). •• Landmark study showing that Punjabiborn residents in the UK have higher blood pressures and more obesity than their siblings still living in Punjab.
23. Syme SL, Marmot MG, Kagan A, Kato H, Rhoads G. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: introduction. Am. J. Epidemiol. 102, 477-480 (1975).
24. Marmot MG, Syme SL, Kagan A, Kato H, Cohen JB, Belsky J. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am. J. Epidemiol. 102, 514-525 (1975).
25. Benfante R. Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review. Hum. Biol. 64, 791-805 (1992).
26. Health and Welfare Statistics Association. Trends for national hygiene 2007 [in Japanese]. J. Health Welfare Stat. 34(47-54), 168-170 (2007).
27. Iso H. Changes in coronary heart disease risk among Japanese. Circulation 118, 2725-2729 (2008).
28. Wolz M, Cutler J, Roccella EJ, Rohde F, Thon T, Burt V. Statement from the National High Blood Pressure Education Program: prevalence of hypertension. Am. J. Hypertens. 13(1), 103-104 (2000). (Pubitemid 30103872)
29. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection and management of cardiovascular risk factors in different ethnic groups in south London. Heart 78, 555-563 (1977).
30. Wild S, McKeigue P. Cross sectional analysis of mortality by country of birth in England and Wales 1970-1992. Br. Med. J. 314, 705-710 (1997).
31. Lane DA, Lip GYH, Beevers DG. Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening project. J. Hypertens. 23, 1347-1353 (2005). •• Confirmed that the observed ethnic differences in heart attacks and strokes were rendered nonsignificant after adjustment for age, BMI, cigarette smoking and blood pressure.
32. Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N. Engl. J. Med. 334, 13-18 (1996).
33. Raleigh VS. Diabetes and hypertension in Britain's ethnic minorities: implications for the future of renal services. Br. Med. J. 314, 209-213 (1997).
34. Gale EA. Should we dump the metabolic syndrome? Yes. Br. Med. J. 336, 640 (2008).
35. Cruickshank JK, Beevers DG. Is blood pressure really "worse" in Black people? Lancet 2, 371-372 (1980).
36. Brown JJ, Lever AF, Robertson JI et al. Are idiopathic hyperaldosteronism and low-renin hypertension variants of essential hypertension? Ann. Clin. Biochem. 16, 380-388 (1979).
37. Kaplan NM. The current epidemic of primary aldosteronism: causes and consequences. J. Hypertens. 22, 863-869 (2004).
38. Matekole M, Affram K, Lee SJ, Howie AJ, Michael J, Adu D. Hypertension and end-stage renal failure in tropical Africa. J. Hum. Hypertens. 7, 443-446 (1993). (Pubitemid 23310605)
39. Freis ED, Materson BJ, Flamenbaum W. Comparison of propranolol or hydrochlorothiazide alone for the treatment of hypertension III. Evaluation of the renin-angiotensin system. Am. J. Med. 74, 1029-1041 (1983).
40. Sagnella GA. Why is plasma renin activity lower in populations of African origin? J. Human. Hypertens. 15, 17-25 (2001).
41. Cruickshank JK, Beevers DG. Epidemiology of hypertension: blood pressure in Blacks and Whites. Clin. Sci. 62, 1-6 (1982).
42. Sever PS, Poulter NR. A hypothesis for the pathogenesis of essential hypertension: the initiating factors. J. Hypertens. 7(Suppl.), S9-S12 (1989).
43. Faulkner B, Kushner H. Effects of chronic sodium loading on cardiovascular response in young Blacks and Whites. Hypertension 15(1), 36-43 (1990). (Pubitemid 20034171)
44. Luft FC, Grim CE, Fineberg N, Weinberger MH. Effects of volume expansion and contraction in normotensive Whites, Blacks and different ages. Circulation 59 (4), 643-650 (1979). (Pubitemid 9154955)
45. He FJ, Markandu ND, Sagnella GA, MacGregor GA. Importance of the renin system in determining blood pressure fall with salt restriction in Black and White hypertensives. Hypertension 32(5), 820-824 (1998).
46. Wright JT Jr, Rahman M, Scarpa A et al. Determinants of salt sensitivity in Black and White normotensive and hypertensive women. Hypertension 42, 1087-1092 (2003). (Pubitemid 37549060)
47. Sehgal AR. Overlap between Whites and Blacks in response to antihypertensive drugs. Hypertension 43(3), 566-572 (2004).
48. Wu J, Kraja AT, Oberman A et al. A summary of the effects of antihypertensive medications on measured blood pressure. Am. J. Hypertens. 18(7), 935-942 (2005). •• Meta-analysis with a large number of trials of antihypertensive therapy in different ethnic groups that suggested a slight trend for the thiazide-type diuretics and the calcium-channel blockers to be marginally more effective in patients of African origin. (Pubitemid 41040264)
49. Williams B, Poulter NR, Brown MJ et al. Guidelines for the management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS IV. J. Hum. Hypertens. 18 (3), 139-185 (2004). •• Guidelines for the management of hypertension. (Pubitemid 38425770)
50. Douglas JG, Bakris GL, Epstein M et al. Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch. Intern. Med. 16, 525-541 (2003).
51. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin-converting- enzyme inhibitor therapy in Black as compared with White patients with left ventricular dysfunction. N. Engl. J. Med. 344, 1351-1357 (2001).
52. Cohn JN, Johnson G, Ziesche S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med. 325, 303-310 (1991).
53. Taylor AL, Zieshhe S, Yancy C et al.; The African American Heart Failure Trial investigators. Combination of isosorbide dinitrate and hydralazine in Blacks with heart failure. N. Engl. J. Med. 351, 2049-2057 (2004).
54. Julius S, Alderman MH, Beevers G et al. Cardiovascular risk reduction in hypertensive Black patients with left ventricular hypertrophy: the LIFE study. J. Am. Coll. Cardiol. 43, 1047-1055 (2004). (Pubitemid 38352987)
55. Agoda LY, Appel L, Bakris GL et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomised controlled trial. JAMA 285, 2719-2728 (2001). (Pubitemid 32525368)
56. Gibbs CG, Lip GYH, Beevers DG. Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br. J. Clin. Pharm. 48(6), 861-865 (1999).
57. McDowell SE, Coleman JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. Br. Med. J. 332, 1177-1180 (2006).
58. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N. Engl. J. Med. 345, 479-486 (2001).
59. Chobanion AV, Bakris Gl, Black HR et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The JNC 7 report. JAMA 289, 2560-2572 (2003).
60. Colhoun HM, Hemingway H, Poulter NR. Socio-economic status and blood pressure; an overview analysis. J. Hum. Hypertens. 12, 91-110 (1998). (Pubitemid 28062124)